Europe API Intermediate Market Size, Share & Industry Trends Analysis Report By Type (Bulk Drug Intermediates, and Chemical Intermediates), By End User (Biotech & Pharmaceutical Companies, CMO), By Application, By Country and Growth Forecast, 2023 - 2030

The Europe API Intermediate Market would witness market growth of 6.7% CAGR during the forecast period (2023-2030).

The prevalence of chronic diseases like cardiac, orthopedic, gastrointestinal, and other conditions is predicted to rise as the senior population grows. As a result, this aspect is anticipated to support the market. Due to several variables, including inactivity, fragility, obesity, and other illnesses, including diabetes and arteriosclerosis, the senior population is particularly vulnerable to cardiac diseases.

Additionally, the alarming rise in comorbid conditions, including diabetes, high cholesterol, and blood pressure, can raise their chance of acquiring heart illnesses. Therefore, the risk of getting cardiac diseases rises as the population ages, leading to a sedentary lifestyle. The demand for cardiovascular medications and the API intermediates used in their formulation is thus expected to rise as the number of older populations suffering from heart disease grows. This reason, therefore, fuels the market's expansion.

As per the UK governments report named “Future of an ageing population”, by 2040, in UK, nearly one in seven people is projected to be aged over 75. By 2037, there are projected to be 1.42 million more households headed by someone aged 85 or over an increase of 161% over 25 years. According to report on the French ageing policy, published by UN; as in other European countries, France faces a continuous and significant increase in the number of elderly people: in 2012, there were 15 million of people aged more than 60 years old in France. This number will reach 24 million in 2060. Considering this rising aging population, the market is anticipated to grow in the region as the aged people are more at a risk of encountering numerous chronic diseases.

The Germany market dominated the Europe API Intermediate Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $14.8 billion by 2030. The UK market is estimated to witness a CAGR of 5.8% during (2023 - 2030). Additionally, The France market would showcase a CAGR of 7.5% during (2023 - 2030).

Based on Type, the market is segmented into Bulk Drug Intermediates, and Chemical Intermediates. Based on End User, the market is segmented into Biotech & Pharmaceutical Companies, CMO, and Others. Based on Application, the market is segmented into Analgesics, Antidiabetic Drugs, Anti-Infective Drugs, Cardiovascular Drugs, Anticancer Drugs, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Worldwide API Intermediate Market is Projected to reach USD 237.7 Billion by 2030, at a CAGR of 7.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cation Pharma, Espee Group, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Cipla Limited, Cambrex Corporation, Vertellus, Dr. Reddy’s Laboratories Ltd., Evonik Industries AG (RAG-Stiftung), Pfizer, Inc., Shree Ganesh Remedies Limited.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Bulk Drug Intermediates
• Chemical Intermediates

By End User

• Biotech & Pharmaceutical Companies
• CMO
• Others

By Application

• Analgesics
• Antidiabetic Drugs
• Anti-Infective Drugs
• Cardiovascular Drugs
• Anticancer Drugs
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Cation Pharma
• Espee Group
• Sandoo Pharmaceuticals and Chemicals Co., Ltd.
• Cipla Limited
• Cambrex Corporation
• Vertellus
• Dr.Reddy’s Laboratories Ltd.
• Evonik Industries AG (RAG-Stiftung)
• Pfizer, Inc.
• Shree Ganesh Remedies Limited

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe API Intermediate Market, by Type
1.4.2 Europe API Intermediate Market, by End User
1.4.3 Europe API Intermediate Market, by Application
1.4.4 Europe API Intermediate Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis

Chapter 4. Strategies Deployed in API Intermediate Market

Chapter 5. Europe API Intermediate Market by Type
5.1 Europe Bulk Drug Intermediates Market by Country
5.2 Europe Chemical Intermediates Market by Country

Chapter 6. Europe API Intermediate Market by End User
6.1 Europe Biotech & Pharmaceutical Companies Market by Country
6.2 Europe CMO Market by Country
6.3 Europe Others Market by Country

Chapter 7. Europe API Intermediate Market by Application
7.1 Europe Analgesics Market by Country
7.2 Europe Antidiabetic Drugs Market by Country
7.3 Europe Anti-Infective Drugs Market by Country
7.4 Europe Cardiovascular Drugs Market by Country
7.5 Europe Anticancer Drugs Market by Country
7.6 Europe Others Market by Country

Chapter 8. Europe API Intermediate Market by Country
8.1 Germany API Intermediate Market
8.1.1 Germany API Intermediate Market by Type
8.1.2 Germany API Intermediate Market by End User
8.1.3 Germany API Intermediate Market by Application
8.2 UK API Intermediate Market
8.2.1 UK API Intermediate Market by Type
8.2.2 UK API Intermediate Market by End User
8.2.3 UK API Intermediate Market by Application
8.3 France API Intermediate Market
8.3.1 France API Intermediate Market by Type
8.3.2 France API Intermediate Market by End User
8.3.3 France API Intermediate Market by Application
8.4 Russia API Intermediate Market
8.4.1 Russia API Intermediate Market by Type
8.4.2 Russia API Intermediate Market by End User
8.4.3 Russia API Intermediate Market by Application
8.5 Spain API Intermediate Market
8.5.1 Spain API Intermediate Market by Type
8.5.2 Spain API Intermediate Market by End User
8.5.3 Spain API Intermediate Market by Application
8.6 Italy API Intermediate Market
8.6.1 Italy API Intermediate Market by Type
8.6.2 Italy API Intermediate Market by End User
8.6.3 Italy API Intermediate Market by Application
8.7 Rest of Europe API Intermediate Market
8.7.1 Rest of Europe API Intermediate Market by Type
8.7.2 Rest of Europe API Intermediate Market by End User
8.7.3 Rest of Europe API Intermediate Market by Application

Chapter 9. Company Profiles
9.1 Cation Pharma
9.1.1 Company Overview
9.1.2 SWOT Analysis
9.2 Espee Group
9.2.1 Company Overview
9.2.2 Recent strategies and developments:
9.2.2.1 Trials and Approvals:
9.3 Sandoo Pharmaceuticals and Chemicals Co., Ltd.
9.3.1 Company Overview
9.3.2 SWOT Analysis
9.4 Cipla Limited
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Cambrex Corporation
9.5.1 Company Overview
9.5.2 Recent strategies and developments:
9.5.2.1 Acquisition and Mergers:
9.5.3 SWOT Analysis
9.6 Vertellus
9.6.1 Company Overview
9.6.2 SWOT Analysis
9.7 Dr. Reddy’s Laboratories Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.6 SWOT Analysis
9.8 Evonik Industries AG (RAG-Stiftung)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Geographical Expansions:
9.8.6 SWOT Analysis
9.9 Pfizer, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional & Segmental Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Geographical Expansions:
9.9.6 SWOT Analysis
9.10. SHREE GANESH REMEDIES LIMITED
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 SWOT Analysis

TABLE 1 Europe API Intermediate Market, 2019 - 2022, USD Million
TABLE 2 Europe API Intermediate Market, 2023 - 2030, USD Million
TABLE 3 Europe API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 4 Europe API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 5 Europe Bulk Drug Intermediates Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Bulk Drug Intermediates Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe Chemical Intermediates Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Chemical Intermediates Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 10 Europe API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 11 Europe Biotech & Pharmaceutical Companies Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe Biotech & Pharmaceutical Companies Market by Country, 2023 - 2030, USD Million
TABLE 13 Europe CMO Market by Country, 2019 - 2022, USD Million
TABLE 14 Europe CMO Market by Country, 2023 - 2030, USD Million
TABLE 15 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 18 Europe API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 19 Europe Analgesics Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Analgesics Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Antidiabetic Drugs Market by Country, 2019 - 2022, USD Million
TABLE 22 Europe Antidiabetic Drugs Market by Country, 2023 - 2030, USD Million
TABLE 23 Europe Anti-Infective Drugs Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Anti-Infective Drugs Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Cardiovascular Drugs Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Cardiovascular Drugs Market by Country, 2023 - 2030, USD Million
TABLE 27 Europe Anticancer Drugs Market by Country, 2019 - 2022, USD Million
TABLE 28 Europe Anticancer Drugs Market by Country, 2023 - 2030, USD Million
TABLE 29 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 30 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 31 Europe API Intermediate Market by Country, 2019 - 2022, USD Million
TABLE 32 Europe API Intermediate Market by Country, 2023 - 2030, USD Million
TABLE 33 Germany API Intermediate Market, 2019 - 2022, USD Million
TABLE 34 Germany API Intermediate Market, 2023 - 2030, USD Million
TABLE 35 Germany API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 36 Germany API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 37 Germany API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 38 Germany API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 39 Germany API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 40 Germany API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 41 UK API Intermediate Market, 2019 - 2022, USD Million
TABLE 42 UK API Intermediate Market, 2023 - 2030, USD Million
TABLE 43 UK API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 44 UK API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 45 UK API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 46 UK API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 47 UK API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 48 UK API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 49 France API Intermediate Market, 2019 - 2022, USD Million
TABLE 50 France API Intermediate Market, 2023 - 2030, USD Million
TABLE 51 France API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 52 France API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 53 France API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 54 France API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 55 France API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 56 France API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 57 Russia API Intermediate Market, 2019 - 2022, USD Million
TABLE 58 Russia API Intermediate Market, 2023 - 2030, USD Million
TABLE 59 Russia API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 60 Russia API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 61 Russia API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 62 Russia API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 63 Russia API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 64 Russia API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 65 Spain API Intermediate Market, 2019 - 2022, USD Million
TABLE 66 Spain API Intermediate Market, 2023 - 2030, USD Million
TABLE 67 Spain API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 68 Spain API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 69 Spain API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 70 Spain API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 71 Spain API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 72 Spain API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 73 Italy API Intermediate Market, 2019 - 2022, USD Million
TABLE 74 Italy API Intermediate Market, 2023 - 2030, USD Million
TABLE 75 Italy API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 76 Italy API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 77 Italy API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 78 Italy API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 79 Italy API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 80 Italy API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 81 Rest of Europe API Intermediate Market, 2019 - 2022, USD Million
TABLE 82 Rest of Europe API Intermediate Market, 2023 - 2030, USD Million
TABLE 83 Rest of Europe API Intermediate Market by Type, 2019 - 2022, USD Million
TABLE 84 Rest of Europe API Intermediate Market by Type, 2023 - 2030, USD Million
TABLE 85 Rest of Europe API Intermediate Market by End User, 2019 - 2022, USD Million
TABLE 86 Rest of Europe API Intermediate Market by End User, 2023 - 2030, USD Million
TABLE 87 Rest of Europe API Intermediate Market by Application, 2019 - 2022, USD Million
TABLE 88 Rest of Europe API Intermediate Market by Application, 2023 - 2030, USD Million
TABLE 89 Key Information – Cation Pharma
TABLE 90 Key Information – Espee Group
TABLE 91 Key Information – Sandoo Pharmaceuticals and Chemicals Co., Ltd.
TABLE 92 Key Information – Cipla Limited
TABLE 93 Key Information – Cambrex Corporation
TABLE 94 Key Information – Vertellus
TABLE 95 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 96 Key Information – Evonik Industries AG
TABLE 97 Key Information – Pfizer, Inc.
TABLE 98 Key Information – SHREE GANESH REMEDIES LIMITED

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe API Intermediate Market, 2019 - 2030, USD Million
FIG 3 Key Impacting Factors API intermediate market
FIG 4 Porter’s Five Forces Analysis – API Intermediate Market
FIG 5 Europe API Intermediate Market share by Type, 2022
FIG 6 Europe API Intermediate Market share by Type, 2030
FIG 7 Europe API Intermediate Market by Type, 2019 - 2030, USD Million
FIG 8 Europe API Intermediate Market share by End User, 2022
FIG 9 Europe API Intermediate Market share by End User, 2030
FIG 10 Europe API Intermediate Market by End User, 2019 - 2030, USD Million
FIG 11 Europe API Intermediate Market share by Application, 2022
FIG 12 Europe API Intermediate Market share by Application, 2030
FIG 13 Europe API Intermediate Market by Application, 2019 - 2030, USD Million
FIG 14 Europe API Intermediate Market share by Country, 2022
FIG 15 Europe API Intermediate Market share by Country, 2030
FIG 16 Europe API Intermediate Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: Cation Pharma
FIG 18 Swot Analysis: Sandoo Pharmaceuticals and Chemicals Co., Ltd.
FIG 19 SWOT Analysis: Cipla Limited
FIG 20 Swot Analysis: Cambrex Corporation
FIG 21 Swot Analysis: Vertellus
FIG 22 Swot Analysis: Dr. Reddy’s Laboratories Ltd.
FIG 23 Recent strategies and developments: Evonik Industries AG
FIG 24 Swot Analysis: Evonik Industries AG
FIG 25 Swot Analysis: Pfizer, Inc.
FIG 26 Swot Analysis: SHREE GANESH REMEDIES LIMITED